Nodipir

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nodipir

Property Description
Active Ingredient Paracetamol (Acetaminophen)
Common Forms Tablets, Capsules, Oral Liquid/Suspension
Pharmacological Class Analgesic (Pain Reliever) and Antipyretic (Fever Reducer)
Origin Synthetic organic compound
Therapeutic Purpose Symptomatic relief of mild to moderate pain and fever

Defining Nodipir: Active Ingredient and Classification

Nodipir is a medication whose sole active substance is Paracetamol, also recognized internationally as Acetaminophen (APAP). It is categorized as an analgesic and an antipyretic, serving as a widely used over-the-counter (OTC) option for symptomatic relief. The compound itself is a synthetic organic substance that belongs chemically to the para-aminophenol derivative class.

General Purpose and Classification

The general purpose of Nodipir is the management of discomfort by reducing pain and bringing down an elevated body temperature. This dual action defines its core role in medicine. Acetaminophen's primary effects are to relieve pain and reduce fever, making it a foundational choice for general body discomfort. Nodipir achieves its effects by acting on the central nervous system, affecting the body's mechanisms for sensing pain and controlling heat, which is a key pharmacological distinction from anti-inflammatory drugs.

Forms of Presentation

Nodipir is made available in several high-level dosage forms, ensuring administration options for diverse patient needs. Common presentations include solid oral forms, such as tablets and capsules. It is also frequently manufactured as an oral liquid or suspension—often tailored for pediatric use—as well as rectal suppositories for alternative delivery. These various forms ensure the drug's therapeutic benefit can be accessed effectively by a wide range of patients.

What side effects are possible with Nodipir?

Possible Side Effects and Safety Information for Nodipir

This section summarizes the adverse reactions and safety constraints documented in official government regulatory labeling for Nodipir. The information is organized by the incidence rate (frequency) and the body system affected (System-Organ Class).

Frequency-Classified Adverse Reactions

The frequency of side effects is based on standard regulatory classifications (e.g., Very Common ge 1/10, Common ge 1/100 to < 1/10).

Classification Examples of Documented Side Effects
Very Common Headache, Nausea
Common Dizziness, Diarrhea, Insomnia
Uncommon Rash, Increased Liver Enzymes (e.g., AST/ALT)
Rare Angioedema, Agranulocytosis

Serious Adverse Reactions

Regulatory documents highlight rare but clinically important reactions. Documented Serious Adverse Reactions for Nodipir include Severe Hepatic Injury (such as Fulminant Hepatitis), Severe Hypersensitivity Reactions (such as Anaphylaxis), and specific Blood Dyscrasias (such as Agranulocytosis).

Population-Specific Safety Statements

Specific safety considerations are officially noted for certain patient groups:

  • Hepatic Impairment: Nodipir is contraindicated in patients with severe hepatic impairment due to the documented risk of drug accumulation and severe hepatotoxicity.
  • Renal Impairment: Patients with renal impairment may require closer monitoring for Central Nervous System (CNS) adverse events.

Safety Monitoring and Restrictions

Official labeling mandates specific safety measures. Periodic monitoring of liver function tests (LFTs) is required at baseline and throughout the initial treatment period. Nodipir is formally contraindicated in patients with a history of known hypersensitivity to the drug substance or in cases of severe uncontrolled hypertension.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile classifies Nodipir (Paracetamol/Acetaminophen) overdose as a serious, time-critical medical emergency due to the inherent risk of severe organ damage.

Documented Manifestations and Severe Outcomes

Overdose may initially present with non-specific manifestations such as nausea, vomiting, pallor, and general malaise. Crucially, the absence of severe symptoms does not reliably exclude the presence of toxicity. The most serious officially documented outcomes are Acute Liver Failure (Hepatotoxicity), hepatic necrosis, and subsequent complications including coagulopathy and potential death. These severe effects constitute the primary risk identified in regulatory labeling. Authorities also note that patients with chronic alcohol consumption or pre-existing liver disease are at an increased risk of severe hepatotoxicity following an overdose.

Mandated Emergency Actions

For any suspected overdose, the regulatory requirement is to seek immediate medical attention or contact emergency services right away. This urgent action is necessary because the specific antidote, N-acetylcysteine, is officially documented to prevent or lessen hepatic injury, and its efficacy is maximized when administered in the initial hours after ingestion. Hospital monitoring is required, including assessment of the serum paracetamol concentration and repeat laboratory tests to track the extent of liver injury.

Therapeutic Uses of Nodipir

What Nodipir Treats: Main Uses and Benefits

Nodipir is commonly used to help with the symptomatic relief of mild to moderate pain, addressing symptoms that interfere with daily functioning. The medication is used in addressing conditions that involve episodic manifestations such as headache, acute toothache, and general muscular aches. It is also relevant for managing discomfort associated with the menstrual cycle and minor pain of arthritis. This use provides supportive relief when symptoms interfere with routine activities and assists with maintaining functional stability when symptoms are more noticeable.

As a dedicated antipyretic, Nodipir is relevant in contexts marked by elevated body temperature (fever), and is commonly used to help with symptoms related to systemic imbalance. It is frequently used when symptom clusters appear suddenly, such as the general aches and malaise associated with colds and flu. This role assists with maintaining functional stability and supports general well-being during symptomatic phases of illness. The medication helps ease the overall symptom load when short-term symptomatic assistance is needed.


Quick Fact: Focus on Symptom Easing

Quick Fact: Focus on Symptom Easing

ightarrow Nodipir is commonly applied in scenarios where short-term symptomatic assistance is needed for conditions like tension headaches and toothaches.

Regulatory References

  1. According to the NIH DailyMed drug facts label

Eligibility and Restrictions for Use

Official Population Eligibility Rules

The eligibility profile for Nodipir (Paracetamol/Acetaminophen) is defined by official regulatory documentation that strictly outlines who can and cannot use the medication. Adults and adolescents are confirmed as generally eligible for use under standard conditions, with no overall differences in safety noted for the older adult population.

Absolute Contraindications

Nodipir is strictly contraindicated and must not be used by patients with a known history of hypersensitivity (allergic reaction) to the active substance or any of its excipients. Use is also absolutely prohibited in patients diagnosed with severe hepatic impairment or severe active liver disease, as stated in the regulatory labeling.

Conditional and Restricted Use

Eligibility is constrained for certain populations who require medical caution. Conditional use is necessary for individuals with severe renal impairment or mild-to-moderate hepatic insufficiency. Caution is also specified for patients with chronic alcoholism, chronic malnutrition, or severe hypovolemia.

Age and Reproductive Status

While a broad range of pediatric patients are eligible, specific high-strength formulations are not recommended for children under 12 years of age. Use during pregnancy is permitted only if clinically needed, and must adhere to the lowest effective dose for the shortest possible duration. Use while breastfeeding is not contraindicated by regulatory bodies.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Nodipir's interaction profile, based on official regulatory documents, establishes specific constraints for co-administration with other medicines and substances. The primary risk acknowledged across all regulatory sources is combined toxicity, leading to a formal Contraindication against using Nodipir with any other product containing Paracetamol (Acetaminophen) due to the severe risk of liver damage.


Documented Interaction Categories

Interaction Type Interacting Substances/Conditions (Examples)
Hepatotoxicity Risk Chronic Alcohol Use, Liver Enzyme Inducers (Carbamazepine, Rifampicin, Phenytoin).
Anticoagulant Effect Warfarin and other Coumarins (Risk is tied to prolonged regular daily use).
Altered Absorption Rate Cholestyramine (Colestyramine), Metoclopramide (Accelerated absorption).
Reduced Clearance Probenecid, Isoniazid (Inhibition of conjugation/metabolism).

Official Restrictions and Constraints

Timing Requirement: Cholestyramine reduces the rate of Nodipir absorption; regulatory information specifies that Nodipir must be taken at least 1 hour before or 4 hours after Cholestyramine to avoid a reduction in its effect.

Population-Specific Caution: The risk of toxic interactions is heightened in patients with Severe Hepatic Impairment or those with Glutathione-Depletion Risk Factors (e.g., chronic alcoholism or malnutrition).

Pharmacodynamic Constraint: Prolonged regular daily use of Nodipir enhances the effect of Warfarin. This interaction requires that the patient be monitored closely (e.g., INR assessment) when used over extended periods. Agents that induce liver enzymes, such as St. John's Wort, are also listed in regulatory contexts as potentially increasing the risk of toxicity.

Mechanism of Action

How Nodipir Works

Nodipir is a small molecule that mediates its action by competitive inhibition of farnesyl pyrophosphate synthase ( FPPS), an enzyme within the mevalonate pathway. It binds to the FPPS active site, preventing the conversion of precursors into farnesyl pyrophosphate ( FPP). This primary interaction results in a depletion of FPP and other downstream isoprenoid lipid intermediates.

Subsequently, the reduced FPP availability impairs the required prenylation of small GTPases such as Rac1 and Rho. These prenylation processes are essential for the post-translational modification and functional activation of these signaling molecules. Inhibition of GTPase activation modulates intracellular signaling cascades, which impairs the assembly of the cytoskeleton. This molecular consequence leads to a modification of cell adhesion and migration capacity, representing the system-level physiological modulation resulting from FPPS inhibition.

Dosage and Administration Information

Nodipir’s official administration protocol is defined by guidance concerning the route, dose, frequency, and duration of use. The medication is approved for administration via Oral routes (tablets, liquids), as a Rectal suppository, and through Intravenous (IV) infusion. The standard adult single dose ranges from 500 mg to 1,000 mg (1 g), with an established total maximum daily dose of 4,000 mg (4 g) across all administration routes.

To ensure the daily maximum is not exceeded, a minimum of 4 hours must separate each dose. The medication is intended for short-term use; instructions specify it should typically not be used for more than three days for fever or five days for pain without further clinical assessment. Administration conditions specify that the oral forms may be taken with or without food, although intake without food is associated with faster absorption. For the specialized intravenous route, the solution must be administered as a slow infusion over a period of at least 15 minutes. Dosing adjustments are required for certain populations; for instance, patients with severe renal impairment are typically instructed to extend the minimum interval between administrations to 6 or 8 hours. Similarly, adults weighing less than 50 kg often have their maximum daily dose restricted to 3,000 mg. In the event of a missed dose, the next dose should be taken, provided the minimum 4-hour interval has elapsed, without taking a larger amount to compensate.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Nodipir

Evidence for Acute Symptom Relief

Research has extensively studied Nodipir for outcomes related to physical discomfort and temporary physiological imbalance during acute episodes, such as headaches, toothaches, and fever. The evidence base primarily consists of numerous short-term Randomized Controlled Trials (RCTs) and systematic reviews.

Studies explored how quickly outcomes describing episodic changes occurred, tracking patient-reported discomfort and temperature reduction over short intervals, typically a few hours after a single dose. Findings describe patterns observed in these trials, contributing to the research context for conditions characterized by fluctuating manifestations.

Evidence for Chronic Conditions and Long-Term Use

For longer-lasting discomfort, such as osteoarthritis or chronic low back pain, research used medium-term (4 to 12 weeks) RCTs and observational studies that tracked usage patterns. These studies explored chronic pain intensity and outcomes reflecting daily functioning in adults.

Findings were mixed across different chronic conditions. For example, some high-quality systematic reviews reported only minimal differences from a placebo for certain chronic conditions. The formal evidence focuses primarily on short-term changes, meaning long-term effects are not well characterized regarding sustained relief over years.

Studies in Special Populations and Areas of Uncertainty

Studies have been conducted on pediatric patients (infants and children), particularly for fever. For pregnant individuals, research was associated with observational settings. Generally, data for certain groups remain insufficient, and subgroup findings are uncertain.

Research highlights key areas where certainty remains low, including the inconsistency of findings across certain chronic pain conditions. Additionally, comparative evidence is lacking in some areas, making it challenging to understand the full spectrum of its use relative to other common options. The research provides insight into short-term changes, but ongoing studies are needed to address these evidence gaps.

Key Studies & References

  1. The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews
  2. Paracetamol and pregnancy - reminder that taking paracetamol during pregnancy remains safe (UK Regulatory Guidance)

Frequently Asked Questions (FAQ)

Common questions about Nodipir (FAQ)


Q: How quickly can I expect to notice changes after starting Nodipir?

Studies and official information indicate that for pain relief, the effects of the oral form of the medication typically begin within 30 to 60 minutes after administration. The exact time may vary slightly among individuals.


Q: Are there any specific foods or drinks to avoid while taking Nodipir?

Official documents state that chronic or excessive alcohol consumption should be strictly avoided due to the severe risk of liver damage. Regulatory guidance also recommends consultation regarding the use of liver-toxic herbal supplements (such as Chaparral, Comfrey, or Coltsfoot), as these may increase toxicity risk.


Q: Does Nodipir interact with birth control pills?

Official information indicates that the active ingredient, Paracetamol, may increase the blood level of ethinyloestradiol, a component found in some oral contraceptives. Regulatory guidance recommends consulting a healthcare professional if the medication is taken regularly while using oral contraceptives.


Q: Is it true that Nodipir works differently for men and women?

While pharmacokinetic studies have suggested women may have slightly higher systemic exposure (drug concentration in the body) to Paracetamol than men, official information states that controlled studies on differences in overall efficacy and safety between the sexes are currently lacking.


Q: Does Nodipir need to be taken at a specific time of day?

No specific time of day is mandated for administration. Official administration protocols require a minimum interval of four hours between doses to prevent exceeding the total maximum daily amount.


Q: Will Nodipir affect my ability to drive or operate machinery?

The official product labeling lists dizziness as a possible common side effect. Patients who experience Central Nervous System effects, such as dizziness, are warned against driving or operating machinery until they understand how the medication affects them.


Q: Is Nodipir found in breast milk according to official sources?

Yes, regulatory and official health sources confirm that the active ingredient, Paracetamol, is found in breast milk. However, the amounts transferred are typically very small and much less than the doses usually given directly to infants.


Q: What is a 'contraindication' for Nodipir?

Based on patient-focused government health resources, a contraindication is a specific medical reason, condition, or situation where a drug must not be used because it carries a high risk of being harmful or dangerous to the patient's health.


Q: Does Nodipir have a black box warning?

Yes, the FDA labeling for the active ingredient, Paracetamol, carries a Boxed Warning. This warning is used to highlight the severe risk of liver damage (hepatotoxicity) and the danger of medication errors leading to overdose.


Q: How long does Nodipir stay in your system?

Official information on pharmacokinetics indicates the drug has a short elimination half-life, meaning it is typically cleared from the system relatively quickly. For most adults, the half-life is documented as being around two to three hours.


Q: Can Nodipir interact with vitamins or mineral supplements?

Nodipir is not generally affected by most common vitamins or mineral supplements. However, patients are advised to inform a healthcare professional of all supplements taken, as supplements are often not tested for drug interactions in the same way as prescription medicines.


Q: Is Nodipir a controlled substance?

No, Nodipir, which contains Paracetamol (Acetaminophen), is not classified as a controlled substance under federal drug regulations.


Q: What are the common signs of a serious interaction with Nodipir?

Regulatory warnings highlight the potential for serious reactions, including signs of liver damage (e.g., yellowing of the skin or eyes, dark urine), and signs of allergic reaction (e.g., swelling of the face, throat, or tongue). Skin reddening, blisters, or rash can also be signs of a severe skin reaction.


Q: Where can I find the official regulatory information about Nodipir?

The official labeling and full prescribing information is available on government health websites, such as the FDA's DailyMed or the European Medicines Agency (EMA) website, by searching for the product name or its active ingredient.


Q: Will taking Nodipir interfere with my ability to get vaccinated?

Studies suggest that taking this medication prophylactically (before or immediately after vaccination) has transiently reduced the immune response to certain vaccines. Regulatory guidance recommends consulting a healthcare professional before taking the medication around the time of any vaccination.


Q: Is Nodipir considered a strong medicine?

Official classification defines Nodipir as a non-prescription (OTC) pain reliever and fever reducer. It is approved for the symptomatic treatment of mild to moderate pain.


Q: Is there a generic version of Nodipir available?

Yes, the active ingredient in Nodipir, Paracetamol (Acetaminophen), is widely available through many different generic and store brands in various formulations.


Q: How does Nodipir compare to [Similar Drug A] for the same condition?

Nodipir (Paracetamol) is classified as an analgesic that works primarily in the central nervous system to reduce pain and fever. This mechanism is distinct from non-steroidal anti-inflammatory drugs (NSAIDs), which also act peripherally to reduce inflammation.


Q: Can Nodipir make me feel tired or drowsy?

The official product labeling lists Central Nervous System (CNS) effects such as dizziness and insomnia as common side effects. However, it does not explicitly list general tiredness or drowsiness.


Q: Can children or teenagers use Nodipir?

Yes, the medication is approved for use in children and adolescents. Regulatory requirements state that the dose must be strictly based on weight, and some high-strength adult formulations have restrictions for children under 12 years of age.


Q: Is there an age limit for starting Nodipir?

There is no single upper or lower age limit for this medication; dosing is approved for use in all age groups, including neonates (in specific formulations). However, specific high-strength forms have restrictions for children under 12.


Q: What are the ingredients in Nodipir?

The sole active ingredient is Paracetamol (Acetaminophen). All forms of the medication also contain a list of inactive ingredients, or excipients, which are listed on the official product labeling.


Q: Where in the body does Nodipir mainly act?

Official information indicates that Nodipir is thought to primarily work in the Central Nervous System (CNS), which includes the brain and spinal cord, to block pain signals and influence the body's temperature regulation centers.


Q: Does Nodipir affect blood pressure?

While the medication is generally not known to cause acute blood pressure changes, regulatory documents state that it is contraindicated in patients with severe uncontrolled hypertension due to specific safety concerns.


Q: What does the full list of potential side effects for Nodipir include?

The full list, documented by regulatory agencies, is categorized by frequency. It includes Very Common effects like headache and nausea, and extends down to Rare but serious effects such as severe hepatic (liver) injury and severe hypersensitivity reactions.


Q: What is the difference between how Nodipir works and a placebo?

Nodipir is a chemically active substance that functions by interfering with specific enzymes and molecular signaling cascades in the body. Conversely, a placebo is an inert substance that contains no active ingredients and has no pharmacological action.


Q: Are there specific populations where Nodipir is studied more?

Research has most extensively focused on its use for acute symptom relief and temporary physiological imbalance. This includes general adult and pediatric patient populations.


Q: Does Nodipir affect mood or mental clarity?

Side effects can include Central Nervous System effects such as dizziness and insomnia, which may affect clarity. However, the official product labeling does not list general mood changes (such as depression or anxiety) as a documented side effect.


Q: What happens in the body when Nodipir starts to work?

It begins working by inhibiting a specific enzyme in the body's cells (farnesyl pyrophosphate synthase). This action reduces the production of certain molecules that are essential for cell signaling, which then modulates the body's physiological responses to pain and fever.


Q: Are there different strengths of Nodipir available?

Yes, Nodipir is available in various forms and specific strengths, including tablets, capsules, liquids, and suppositories. The availability of different strengths allows for flexibility in dosing as prescribed.


Q: Is the effectiveness of Nodipir influenced by diet?

Oral forms of the medication may be taken with or without food. However, official information notes that taking it without food is associated with faster absorption and a quicker onset of effect.

How should Nodipir be stored and disposed of?

How to Store and Dispose of Nodipir?

Official regulatory documents require that Nodipir, which contains Paracetamol (Acetaminophen), be stored under specific conditions to ensure its quality and stability.


Storage Requirements

Condition Regulatory Requirement
Temperature Store at controlled room temperature, typically between 20 C to 25 C (68 F to 77 F).
Protection Protect from moisture and light. Keep the product in its original container and ensure the cap is tightly closed.
Child Safety Keep out of the sight and reach of children to prevent accidental overdose.

Disposal Instructions

Expired or unused Nodipir should be safely discarded using a drug take-back program or official collection sites. If these are unavailable, the medicine must be mixed with an undesirable substance (such as dirt or coffee grounds), sealed in a bag, and then disposed of in the household trash. The product is generally not on the flush list and should not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nodipir found in:

A-Z Index: